NO940991L - Forebyggelse av hemolyse - Google Patents

Forebyggelse av hemolyse

Info

Publication number
NO940991L
NO940991L NO940991A NO940991A NO940991L NO 940991 L NO940991 L NO 940991L NO 940991 A NO940991 A NO 940991A NO 940991 A NO940991 A NO 940991A NO 940991 L NO940991 L NO 940991L
Authority
NO
Norway
Prior art keywords
hemolysis
prevention
compositions
hemolytic activity
preventing
Prior art date
Application number
NO940991A
Other languages
English (en)
Other versions
NO940991D0 (no
Inventor
Paul B Weisz
Edward J Macarak
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Publication of NO940991D0 publication Critical patent/NO940991D0/no
Publication of NO940991L publication Critical patent/NO940991L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Preparater og fremgangsmåter for forebyggelse eller i alt vesentlig inhibering av den hemolytiske aktivitet av hemolyseinduserende midler. Frem-gangsmåten og preparatene er basert på anvendelse av et anionisk oligo-sakkarid, slik som polysulfatert syklodekstrin, for å oppnå den ønskede reduksjon i hemolytisk aktivitet.
NO940991A 1991-09-19 1994-03-18 Forebyggelse av hemolyse NO940991L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/762,606 US5446030A (en) 1991-09-19 1991-09-19 Prevention of hemolysis
PCT/US1992/008037 WO1993005791A1 (en) 1991-09-19 1992-09-18 Prevention of hemolysis

Publications (2)

Publication Number Publication Date
NO940991D0 NO940991D0 (no) 1994-03-18
NO940991L true NO940991L (no) 1994-05-18

Family

ID=25065556

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940991A NO940991L (no) 1991-09-19 1994-03-18 Forebyggelse av hemolyse

Country Status (9)

Country Link
US (2) US5446030A (no)
EP (1) EP0649308A1 (no)
JP (1) JPH06511006A (no)
AU (1) AU2683292A (no)
BR (1) BR9206515A (no)
CA (1) CA2119005A1 (no)
FI (1) FI941292L (no)
NO (1) NO940991L (no)
WO (1) WO1993005791A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658894A (en) * 1989-04-23 1997-08-19 The Trustees Of The University Of Pennsylvania Compositions for inhibiting restenosis
CA2481306A1 (en) * 2002-04-09 2003-10-23 Greenville Hospital System Metastasis modulating activity of highly sulfated oligosaccharides
US7151091B2 (en) * 2002-09-20 2006-12-19 The Johns Hopkins University Compositions and methods for preventing infection
US8968992B2 (en) * 2008-03-21 2015-03-03 Fenwal, Inc. Red blood cell storage medium for extended storage
US8871434B2 (en) * 2008-03-21 2014-10-28 Fenwal, Inc. Red blood cell storage medium for extended storage
PL2434886T3 (pl) 2009-05-29 2020-05-18 Cydex Pharmaceuticals, Inc. Kompozycje do wstrzykiwania melfalanu zawierające pochodną cyklodekstryny i sposoby ich wytwarzania i stosowania
US11020363B2 (en) 2009-05-29 2021-06-01 Cydex Pharmaceuticals, Inc. Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
US11864553B2 (en) 2009-10-23 2024-01-09 Fenwal, Inc. Methods and systems for providing red blood cell products with reduced plasma
WO2012175434A1 (en) 2011-06-20 2012-12-27 Glaxo Group Limited Pharmaceutical formulations comprising vestipitant

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH445129A (fr) * 1964-04-29 1967-10-15 Nestle Sa Procédé pour la préparation de composés d'inclusion à poids moléculaire élevé
JPS5036422A (no) * 1973-08-07 1975-04-05
JPS5311000B2 (no) * 1974-04-18 1978-04-18
US4020160A (en) * 1975-08-15 1977-04-26 American Cyanamid Company Cyclodextrin sulfate salts as complement inhibitors
US4066829A (en) * 1976-07-12 1978-01-03 American Cyanamid Company Malto-dextrin poly(H-)sulfates
JPS5336220A (en) * 1976-09-16 1978-04-04 Mitsubishi Electric Corp Ultrasonic atomizer
US4258180A (en) * 1979-11-05 1981-03-24 American Cyanamid Company C6-Modified cyclodextrin sulfate salts as complement inhibitors
US4247535A (en) * 1979-11-05 1981-01-27 American Cyanamid Company Modified cyclodextrin sulfate salts as complement inhibitors
DE2947742C2 (de) * 1979-11-27 1986-04-03 Koch, Jürgen, Dr., 2000 Hamburg Arzneimittel, enthaltend β-Cyclodextrin
US4383992A (en) * 1982-02-08 1983-05-17 Lipari John M Water-soluble steroid compounds
HU190584B (en) * 1983-03-11 1986-09-29 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara,Rt,Hu Process for the production of heptakis/2,6-di-o-methyl-beta-cyclodextrin
EP0146841A3 (de) * 1983-12-17 1986-11-20 Consortium für elektrochemische Industrie GmbH Wasserlösliche Mischether des beta-Cyclodextrins und ein Verfahren zu ihrer Herstellung
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
US4596795A (en) * 1984-04-25 1986-06-24 The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
US4703042A (en) * 1984-05-21 1987-10-27 Bodor Nicholas S Orally active heparin salts containing multivalent cationic units
JPS61165322A (ja) * 1985-01-14 1986-07-26 Microbial Chem Res Found スパガリン類の注射用凍結乾燥製剤
JPH0651725B2 (ja) * 1985-02-28 1994-07-06 メルシャン株式会社 部分メチル化シクロデキストリン及びその製造方法
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
JPS62123196A (ja) * 1985-11-22 1987-06-04 Nisshin Flour Milling Co Ltd プレドニゾロン包接化合物
EP0240098A3 (en) * 1986-04-04 1989-05-10 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Oligo and polysaccharides for the treatment of diseases caused by retroviruses
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
JPH085923B2 (ja) * 1986-11-12 1996-01-24 和光純薬工業株式会社 新規なシクロデキストリン誘導体及びその製法
AU610120B2 (en) * 1987-01-13 1991-05-16 Kao Corporation Hemolysis depressent and blood preserving composition
US4877778A (en) * 1987-07-01 1989-10-31 The Children's Medical Center Corporation Method of enhancing lipophile transport using cyclodextrin derivatives
US4877774A (en) * 1987-09-09 1989-10-31 The United States Of America As Represented By The Department Of Health And Human Services Administration of steroid hormones
HU201783B (en) * 1987-10-13 1990-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing partially methylized carboxy-acyl-beta-cyclodextrines and salts
US5068226A (en) * 1987-12-07 1991-11-26 Cyclex, Inc. Pharmaceutical preparations containing cyclodextrins and their use in iontophoretic therapies
US5017566A (en) * 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5183809A (en) * 1990-02-15 1993-02-02 The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation Cyclodextrin polymers and cyclodextrins immobilized on a solid surface
ES2059571T3 (es) * 1988-01-19 1994-11-16 Takeda Chemical Industries Ltd Fumagilina como agente angiostatico.
KR900700114A (ko) * 1988-01-19 1990-08-11 모세 쥬다 포크만 성장억제 작용제 및 그 사용법
US5019562A (en) * 1988-01-19 1991-05-28 The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation Growth inhibiting agent and the use thereof
JP2751344B2 (ja) * 1988-03-18 1998-05-18 武田薬品工業株式会社 β―シクロデキストリン硫酸エステル塩の精製方法
US4902788A (en) * 1988-09-29 1990-02-20 Uop Crosslinked cyclodextrins supported on porous refractory inorganic oxides
DK0447171T3 (da) * 1990-03-15 1994-12-12 Tanabe Seiyaku Co Polysulfat af cyclodextrinderivat og fremgangsmåde til fremstilling deraf
US5100878A (en) * 1990-05-07 1992-03-31 American Maize-Products Company Blocking the effect of teratogens on a fetus

Also Published As

Publication number Publication date
NO940991D0 (no) 1994-03-18
WO1993005791A1 (en) 1993-04-01
AU2683292A (en) 1993-04-27
CA2119005A1 (en) 1993-04-01
FI941292A0 (fi) 1994-03-18
JPH06511006A (ja) 1994-12-08
EP0649308A1 (en) 1995-04-26
US5776914A (en) 1998-07-07
US5446030A (en) 1995-08-29
BR9206515A (pt) 1995-10-31
FI941292A7 (fi) 1994-05-18
FI941292L (fi) 1994-05-18
EP0649308A4 (en) 1994-06-22

Similar Documents

Publication Publication Date Title
NO971622D0 (no) Saponinpreparater og anvendelse derav i immunstimulerende komplekser
DE69032434D1 (de) Synergistische mikrobizide Kombinationen
ATE233738T1 (de) Kleine moleküle anwendbar in der behandlung von entzündgskrankheiten
MD1838G2 (ro) Derivaţi de 5,6-diclorbenzimidazol, procedeu de obţinere a lor, compoziţie farmaceutică şi metodă de tratament sau de prevenire a infecţiei virotice herpetice
FI955527A0 (fi) Aerogeelien alikriittinen kuivausmenetelmä
NO954320L (no) Lyosfærer omfattende gonadotropin
DK0744902T3 (da) Sportsdrik
DE59209810D1 (de) Bestimmung von peptidmotiven auf mhc-molekülen
NO990497L (no) Modifiserte oligosakkarider
ATE210147T1 (de) Glycokonjugate von modifizierten camptothecin- derivaten(a- oder b-ring-verknüpfung)
NO940991L (no) Forebyggelse av hemolyse
NO940266L (no) Indre strålingsskade
GB9123339D0 (en) Data-loss prevention products
ES2125976T3 (es) Otros derivados de indol con accion antiviral.
HUT68239A (en) Process for producing inclusion complexes of nimesulide alkali salts with cyclodextrins or cyclodextrin derivatives and pharmaceutical preparations containing them
ATE148471T1 (de) Polysaccharide aus glykogen
ATE131005T1 (de) Gel erhalten durch komplexierung von stärke und emulgator.
DK0666739T3 (da) Intravenøs opløsning som formindsker protein- og vandtab fra kroppen
FI102078B1 (fi) Alkoholeja lohkaisemalla elastomeereiksi verkkoutettavat organo(poly)siloksaanimassat
NO890046L (no) Disubstituerte pyridiner.
DK0479093T3 (da) Oligosaccharidderivater og deres anvendelse som lægemidler
FR2709061B1 (fr) Utilisation d'oligosaccharides dans la prévention et le traitement du vieillissement des tissus.
DE69022845D1 (en) Erythromycinderivate.
FR2687933B1 (fr) Produits antimottants, compositions contenant ces produits et traitements mettant ces produits en óoeuvre.
DK578887D0 (da) Antihypertensiva